Pharvaris N.V.
PHVS
$35.14
$1.103.23%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
8/14/2026
-
The Cerbat Gem
8/14/2026
-
TipRanks
8/13/2026
-
MarketBeat
8/13/2026
-
The Cerbat Gem
8/13/2026
-
MarketBeat
8/13/2026
-
Tickeron - Stocks
8/13/2026
-
MarketBeat
8/13/2026
-
Tickeron - Stocks
8/12/2026
-
MarketBeat
8/12/2026
-
MarketBeat
8/12/2026
-
Globe Newswire
8/12/2026
-
MarketBeat
8/10/2026
-
TipRanks
8/10/2026
-
MarketBeat
8/9/2026
-
Simply Wall St
8/8/2026
-
Tickeron - Stocks
8/7/2026
-
Insider Monkey
8/7/2026
-
MarketBeat
8/6/2026
-
Globe Newswire
8/5/2026
-
Tickeron - Stocks
8/5/2026
-
Tickeron - Stocks
8/4/2026
-
MarketBeat
8/4/2026
-
SeekingAlpha
8/4/2026
-
Seeking Alpha - Long Ideas
8/2/2026
-
MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Wednesday, August 12, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 9 and 13 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
31 712036410
Address
Grafenauweg 8
Zug, 6300
Zug, 6300
Country
Year Founded
Business Description
Sector
Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other...
more